Skip to main content
Top
Published in: BMC Pediatrics 1/2020

01-12-2020 | Septicemia | Research article

Impact of rapid enterovirus polymerase chain reaction testing on management of febrile young infants < 90 days of age with aseptic meningitis

Authors: Paolo Paioni, Florence Barbey, Christa Relly, Patrick Meyer Sauteur, Christoph Berger

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Diagnostic evaluation of febrile young infants is challenging. Empirical antimicrobial treatment is therefore common practice in this setting despite high percentage of causative viral infections. The objective of this study was to investigate the impact of rapid enterovirus cerebrospinal fluid polymerase chain reaction (CSF EV PCR) test on hospital length of stay (LOS) and antimicrobial treatment duration in young febrile infants.

Methods

Retrospective observational study comparing duration of antimicrobial treatment and hospital LOS before (May 1, 2014 - May 30, 2015, untested group) and after (June 1, 2015 - June 30, 2017, tested group) the introduction of rapid CSF EV PCR testing in infants < 90 days of age presenting with fever and CSF pleocytosis at the University Children’s Hospital Zurich. Additionally, the same variables were compared after test introduction between CSF EV PCR positive and negative children.

Results

One hundred twenty-eight children were enrolled in the study, 58 before and 70 after the introduction of rapid CSF EV PCR testing. Duration of antimicrobial treatment was significantly shortened in EV positive (n = 42) compared to both EV negative (n = 28) (median 18 h and 48 h, respectively, p < 0.001) and untested patients (n = 58) (median 18 h and 48 h, respectively, p < 0.001), and also in tested compared to untested group patients (median 36 vs 48 h, p < 0.001). Hospital LOS was significantly shortened in EV positive compared to EV negative patients (median 3 days and 4 days respectively, p = 0.013), while an overall reduction was not observed between tested and untested group patients.

Conclusions

In this study we demonstrate that antimicrobial treatment duration could be significantly shortened in neonates and young infants < 90 days of age with aseptic meningitis after the introduction of a rapid CSF EV PCR test compared to untested patients before test introduction.
Literature
1.
go back to reference de Jong EP, van den Beuken MGA, van Elzakker EPM, Wolthers KC, Sprij AJ, Lopriore E, et al. Epidemiology of Sepsis-like illness in young infants: major role of Enterovirus and human Parechovirus. Pediatr Infect Dis J. 2018;37(2):113–8.CrossRef de Jong EP, van den Beuken MGA, van Elzakker EPM, Wolthers KC, Sprij AJ, Lopriore E, et al. Epidemiology of Sepsis-like illness in young infants: major role of Enterovirus and human Parechovirus. Pediatr Infect Dis J. 2018;37(2):113–8.CrossRef
2.
go back to reference Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco AC, Tsouros S, et al. Diagnosis and management of febrile infants (0–3 months). Evid Rep Technol Assess (Full Rep). 2012;205:1–297. Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco AC, Tsouros S, et al. Diagnosis and management of febrile infants (0–3 months). Evid Rep Technol Assess (Full Rep). 2012;205:1–297.
3.
go back to reference Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics. 1990;85(6):1040–3.PubMed Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics. 1990;85(6):1040–3.PubMed
4.
go back to reference Aronson PL, Lyons TW, Cruz AT, Freedman SB, Okada PJ, Fleming AH, et al. Impact of Enteroviral polymerase chain reaction testing on length of stay for infants 60 days old or younger. J Pediatr. 2017;189:169–74 e2.CrossRef Aronson PL, Lyons TW, Cruz AT, Freedman SB, Okada PJ, Fleming AH, et al. Impact of Enteroviral polymerase chain reaction testing on length of stay for infants 60 days old or younger. J Pediatr. 2017;189:169–74 e2.CrossRef
5.
go back to reference Byington CL, Taggart EW, Carroll KC, Hillyard DR. A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics. 1999;103(3):E27.CrossRef Byington CL, Taggart EW, Carroll KC, Hillyard DR. A polymerase chain reaction-based epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics. 1999;103(3):E27.CrossRef
6.
go back to reference King RL, Lorch SA, Cohen DM, Hodinka RL, Cohn KA, Shah SS. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics. 2007;120(3):489–96.CrossRef King RL, Lorch SA, Cohen DM, Hodinka RL, Cohn KA, Shah SS. Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger. Pediatrics. 2007;120(3):489–96.CrossRef
7.
go back to reference Nigrovic LE, Malley R, Agrawal D, Kuppermann N. Pediatric emergency medicine collaborative research Committee of the American Academy of P. low risk of bacterial meningitis in children with a positive enteroviral polymerase chain reaction test result. Clin Infect Dis. 2010;51(10):1221–2.CrossRef Nigrovic LE, Malley R, Agrawal D, Kuppermann N. Pediatric emergency medicine collaborative research Committee of the American Academy of P. low risk of bacterial meningitis in children with a positive enteroviral polymerase chain reaction test result. Clin Infect Dis. 2010;51(10):1221–2.CrossRef
8.
go back to reference Wallace SS, Lopez MA, Caviness AC. Impact of Enterovirus testing on resource use in febrile young infants: a systematic review. Hosp Pediatr. 2017;7(2):96–102.CrossRef Wallace SS, Lopez MA, Caviness AC. Impact of Enterovirus testing on resource use in febrile young infants: a systematic review. Hosp Pediatr. 2017;7(2):96–102.CrossRef
9.
go back to reference Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics. 2000;105(2):316–9.CrossRef Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics. 2000;105(2):316–9.CrossRef
10.
go back to reference Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283(20):2680–5.CrossRef Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283(20):2680–5.CrossRef
11.
go back to reference Tan NW, Lee EY, Khoo GM, Tee NW, Krishnamoorthy S, Choong CT. Cerebrospinal fluid white cell count: discriminatory or otherwise for enteroviral meningitis in infants and young children? J Neuro-Oncol. 2016;22(2):213–7. Tan NW, Lee EY, Khoo GM, Tee NW, Krishnamoorthy S, Choong CT. Cerebrospinal fluid white cell count: discriminatory or otherwise for enteroviral meningitis in infants and young children? J Neuro-Oncol. 2016;22(2):213–7.
12.
go back to reference Yun KW, Choi EH, Cheon DS, Lee J, Choi CW, Hwang H, et al. Enteroviral meningitis without pleocytosis in children. Arch Dis Child. 2012;97(10):874–8.CrossRef Yun KW, Choi EH, Cheon DS, Lee J, Choi CW, Hwang H, et al. Enteroviral meningitis without pleocytosis in children. Arch Dis Child. 2012;97(10):874–8.CrossRef
13.
go back to reference Chakrabarti P, Warren C, Vincent L, Kumar Y. Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall. UK Eur J Pediatr. 2018;177(10):1523–9.CrossRef Chakrabarti P, Warren C, Vincent L, Kumar Y. Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall. UK Eur J Pediatr. 2018;177(10):1523–9.CrossRef
14.
go back to reference Dewan M, Zorc JJ, Hodinka RL, Shah SS. Cerebrospinal fluid enterovirus testing in infants 56 days or younger. Arch Pediatr Adolesc Med. 2010;164(9):824–30.CrossRef Dewan M, Zorc JJ, Hodinka RL, Shah SS. Cerebrospinal fluid enterovirus testing in infants 56 days or younger. Arch Pediatr Adolesc Med. 2010;164(9):824–30.CrossRef
15.
go back to reference Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J. 1999;18(6):533–7.CrossRef Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J. 1999;18(6):533–7.CrossRef
16.
go back to reference Archimbaud C, Chambon M, Bailly JL, Petit I, Henquell C, Mirand A, et al. Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol. 2009;81(1):42–8.CrossRef Archimbaud C, Chambon M, Bailly JL, Petit I, Henquell C, Mirand A, et al. Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol. 2009;81(1):42–8.CrossRef
17.
go back to reference Huizing KM, Swanink CM, Landstra AM, van Zwet AA, van Setten PA. Rapid enterovirus molecular testing in cerebrospinal fluid reduces length of hospitalization and duration of antibiotic therapy in children with aseptic meningitis. Pediatr Infect Dis J. 2011;30(12):1107–9.CrossRef Huizing KM, Swanink CM, Landstra AM, van Zwet AA, van Setten PA. Rapid enterovirus molecular testing in cerebrospinal fluid reduces length of hospitalization and duration of antibiotic therapy in children with aseptic meningitis. Pediatr Infect Dis J. 2011;30(12):1107–9.CrossRef
18.
go back to reference Lyons TW, McAdam AJ, Cohn KA, Monuteaux MC, Nigrovic LE. Impact of in-hospital enteroviral polymerase chain reaction testing on the clinical management of children with meningitis. J Hosp Med. 2012;7(7):517–20.CrossRef Lyons TW, McAdam AJ, Cohn KA, Monuteaux MC, Nigrovic LE. Impact of in-hospital enteroviral polymerase chain reaction testing on the clinical management of children with meningitis. J Hosp Med. 2012;7(7):517–20.CrossRef
19.
go back to reference Archimbaud C, Ouchchane L, Mirand A, Chambon M, Demeocq F, Labbe A, et al. Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods. PLoS One. 2013;8(7):e68571.CrossRef Archimbaud C, Ouchchane L, Mirand A, Chambon M, Demeocq F, Labbe A, et al. Improvement of the management of infants, children and adults with a molecular diagnosis of Enterovirus meningitis during two observational study periods. PLoS One. 2013;8(7):e68571.CrossRef
20.
go back to reference Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart H, Glode MP. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J. 2002;21(4):283–6.CrossRef Robinson CC, Willis M, Meagher A, Gieseker KE, Rotbart H, Glode MP. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J. 2002;21(4):283–6.CrossRef
21.
go back to reference Stellrecht KA, Harding I, Woron AM, Lepow ML, Venezia RA. The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management. J Clin Virol. 2002;25(Suppl 1):S19–26.CrossRef Stellrecht KA, Harding I, Woron AM, Lepow ML, Venezia RA. The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management. J Clin Virol. 2002;25(Suppl 1):S19–26.CrossRef
22.
go back to reference Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11(6):423–31.CrossRef Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11(6):423–31.CrossRef
23.
go back to reference Bonadio WA, Stanco L, Bruce R, Barry D, Smith D. Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J. 1992;11(7):589–91.CrossRef Bonadio WA, Stanco L, Bruce R, Barry D, Smith D. Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J. 1992;11(7):589–91.CrossRef
24.
go back to reference Dierig A, Berger C, Agyeman PKA, Bernhard-Stirnemann S, Giannoni E, Stocker M, et al. Time-to-positivity of blood cultures in children with Sepsis. Front Pediatr. 2018;6:222.CrossRef Dierig A, Berger C, Agyeman PKA, Bernhard-Stirnemann S, Giannoni E, Stocker M, et al. Time-to-positivity of blood cultures in children with Sepsis. Front Pediatr. 2018;6:222.CrossRef
25.
go back to reference Martinez Planas A, Munoz Almagro C, Luaces Cubells C, Noguera Julian A, Selva L, Fernandez JP, et al. Low prevalence of invasive bacterial infection in febrile infants under 3 months of age with enterovirus infection. Clin Microbiol Infect. 2012;18(9):856–61.CrossRef Martinez Planas A, Munoz Almagro C, Luaces Cubells C, Noguera Julian A, Selva L, Fernandez JP, et al. Low prevalence of invasive bacterial infection in febrile infants under 3 months of age with enterovirus infection. Clin Microbiol Infect. 2012;18(9):856–61.CrossRef
Metadata
Title
Impact of rapid enterovirus polymerase chain reaction testing on management of febrile young infants < 90 days of age with aseptic meningitis
Authors
Paolo Paioni
Florence Barbey
Christa Relly
Patrick Meyer Sauteur
Christoph Berger
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02066-0

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue